ScreenerHero

OPK OPKO Health, Inc.

NAS · US · Healthcare · Diagnostics & Research · opko.com
1.370USD-1.44%Mkt Cap: 1.02B $P/E: —

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutic…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$241.07BUSDP/E 35.1
DHR
Danaher Corporation
$152.87BUSDP/E 38.8
NTRA
Natera, Inc.
$56.33BUSD
A
Agilent Technologies, Inc.
$47.41BUSDP/E 33.2
LONN
Lonza Group AG
$44.91BUSDP/E 37.3
IQV
IQVIA Holdings Inc.
$42.61BUSDP/E 32.2
WAT
Waters Corporation
$42.13BUSDP/E 108.6
IDXX
IDEXX Laboratories, Inc.
$40.48BUSDP/E 36.1
ILMN
Illumina, Inc.
$39.95BUSDP/E 49.4
MTD
Mettler-Toledo International Inc.
$30.65BUSDP/E 34.5
LH
Labcorp Holdings Inc.
$25.48BUSDP/E 26.0
DGX
Quest Diagnostics Incorporated
$25.48BUSDP/E 24.5
GH
Guardant Health, Inc.
$22.22BUSD
RVTY
Revvity, Inc.
$16.98BUSDP/E 72.8
MEDP
Medpace Holdings, Inc.
$16.82BUSDP/E 35.4
ERF
Eurofins Scientific SE
$14.08BUSDP/E 26.3
CRL
Charles River Laboratories International, Inc.
$14.23BUSD
ICLR
ICON Public Limited Company
$12.69BUSDP/E 173.2
BIM
bioMérieux S.A.
$10.31BUSDP/E 20.6
QGEN
Qiagen N.V.
$9.20BUSDP/E 22.6

Key Statistics

Company
Market Cap1.02B USD
Enterprise Value1.19B USD
Revenue (TTM)587.90M USD
Gross Profit205.94M USD
Net Income (TTM)-225.68M USD
Revenue/Share0.75 USD
Last Price1.370 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.3K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.31
PEG93.65
EV/EBITDA-15.18
EV/Revenue2.02
P/S1.85
P/B0.92
EPS (TTM)-0.08
EPS (Forward)-0.28
52W Range
0.980051% of range1.745
52W High1.745 USD
52W Low0.9800 USD
Profitability
Gross Margin33.93%
Oper. Margin-15.31%
EBITDA Margin-13.30%
Profit Margin-37.19%
ROE-17.80%
ROA-11.68%
Growth
Revenue Growth4.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-178.54M USD
CapEx (TTM)12.28M USD
FCF Margin9.31%
FCF Yield5.36%
Net Debt97.32M USD
Net Debt/EBITDA-1.24
Balance Sheet
Debt/Equity0.31
Current Ratio3.35
Quick Ratio2.65
Book Value/Sh1.59 USD
Cash/Share0.40 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.375 USD
Upside (mean)+219.3%
Target Range3.000 USD – 8.500 USD
3.000+219.3% to mean8.500
# Analysts4
Ownership
Shares Out.746.33M
Float323.73M
Insiders50.52%
Institutions27.56%
Short Interest
Short Ratio12.2d
Short % Float8.68%
Short % Out.4.82%
Shares Short35.99M
Short (prev mo.)33.65M
Technical
SMA 501.509 (-9.2%)
SMA 2001.324 (+3.5%)
Beta1.50
S&P 52W Chg16.45%
Avg Vol (30d)2.82M
Avg Vol (10d)1.97M
Technical Indicators
RSI (14)34.7
MACD-0.0114
MACD Signal0.0263
MACD Hist.-0.0377
BB Upper1.761 USD
BB Middle1.576 USD
BB Lower1.391 USD
BB Width23.53%
ATR (14)0.0690 USD
Vol Ratio (20d)1.03x